Use of reboxetine for the treatment of pain

Details for Australian Patent Application No. 2005256944 (hide)

Owner Pfizer Inc.

Inventors Hughes, Bernadette; Stoker, Malcolm, John; McKenzie, Ian

Agent Shelston IP

Pub. Number AU-A-2005256944

PCT Pub. Number WO2006/000903

Priority 60/634,427 07.12.04 US; 0425061.9 12.11.04 GB; 60/588,652 16.07.04 US; 0412878.1 09.06.04 GB

Filing date 27 May 2005

Wipo publication date 5 January 2006

International Classifications

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2006/000903 Priority application(s): WO2006/000903

9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005256945-Preparation of pregabalin and related compounds

2005256935-Increasing portability of documentbased user interface software objects